| ADE | Antibody dependent enhancement |
| BEI | Binary ethyleneimine |
| CDR | Complementary Determining Region |
| CNS | Central Nervous System |
| CV-A16 | Coxsackievirus 16 |
| EMEA | European Medicine Agency |
| EV-A71 | Enterovirus A 71 |
| Fab | Fragment antigen-binding |
| FcR | Fc Receptor |
| FDA | Food and Drug Administration |
| HFMD | Hand, Foot and Mouth Disease |
| mTLNE | Multiple tandem linear neutralizing epitope |
| RD | Rhabdomyosarcoma |
| r.m.s.d | Root Mean Square Deviation |
| RNA | Ribonucleic Acid |
| Trx | Thioredoxin |
| UTR | Untranslated Region |
| VCV | Varicella-zoster virus |
| VLP | Virus-Like-Particle |